INIS
patients
100%
potassium iodides
91%
proliferation
79%
in-situ hybridization
75%
chromosomes
70%
populations
62%
boron chlorides
61%
detection
55%
epithelium
54%
myeloid leukemia
54%
cancer
53%
humans
49%
carcinomas
48%
data
38%
malignancies
37%
bone marrow
37%
blasts
36%
instability
35%
fluorescence
35%
maturation
32%
transformations
30%
dna
29%
pathogenesis
29%
biological markers
28%
zones
27%
compartments
26%
diseases
26%
gain
25%
adenocarcinomas
24%
methylation
24%
Keyphrases
Myelodysplastic Syndrome
91%
Anti-apoptotic
69%
B-cell Lymphoma 2 (Bcl-2)
58%
Cell Population
56%
Acute Myeloid Leukemia
55%
Ki-67
50%
Uterine Cervix
48%
In Situ Hybridization
45%
Ki-67 Index
41%
Flow Cytometry
38%
High-grade Cervical Intraepithelial Neoplasia
37%
Blast Cells
36%
Chromosomal Instability
35%
Myeloid Malignancies
35%
High-risk Human Papillomavirus (HR-HPV)
35%
Chromosome 7
33%
Premalignant Lesions
32%
Nonmalignant
31%
Fluorescence in Situ Hybridization
29%
CD34
29%
Sex-determining Region Y-box 2 (SOX2)
28%
Maturation Stage
27%
Laryngeal Lesions
25%
Proliferation Index
25%
SOX17
25%
Bone Marrow Aspirate
24%
Bone Marrow Cells
24%
Gating Strategy
23%
Topical Imiquimod
23%
5-hydroxymethylcytosine (5hmC)
23%
Medicine and Dentistry
Myelodysplastic Syndrome
51%
Uterine Cervix
49%
Cervical Intraepithelial Neoplasia
47%
Antiapoptotic
44%
Flow Cytometry
44%
Myeloid Malignancy
38%
Squamous Epithelium
36%
Wart Virus
35%
Chromosomal Instability
35%
Cell Population
30%
Larynx Injury
25%
Acute Myeloid Leukemia
24%
Methylation
24%
Imiquimod
23%
5 Hydroxymethylcytosine
23%
Protein P53
23%
Biological Marker
20%
Immunohistochemistry
20%
Squamous Cell Carcinoma
20%
Infection
19%
Myeloid Cell
17%
Cell Lineage
17%
Cervical Cancer
17%
Hematopoietic Cell
16%
Maturation
16%
Adenocarcinoma
16%
5 Methylcytosine
16%
Bone Marrow Cell
16%
In Situ Hybridization
15%
Cell Compartment
15%
